Org.nr 990 646 066 2012 → 2013 Year-over-year analysis

NYKODE THERAPEUTICS ASA: årsregnskap 2013 vs 2012

Grew 332% on revenue, fresh owner capital

approved 2014-04-09; registry 2014-07-24; journal 2014 606075

Summary

What changed

Comparing Årsregnskap 2013 with 2012 for NYKODE THERAPEUTICS ASA. Revenue 1.15m NOK → 4.95m NOK (+332.2%). Equity 108.6k NOK → 9.23m NOK.

On the constructive side: revenue rose; equity strengthened; cash rose. Pressures included: operating result weakened.

Also worth watching: payroll increased. All figures are taken from the published annual accounts for NYKODE THERAPEUTICS ASA.

At a glance

Revenue

1.15m NOK 4.95m NOK

+332.2%

Operating result

-2.68m NOK -3.47m NOK

-29.6%

Equity

108.6k NOK 9.23m NOK

+8403.0%

Cash

6.38m NOK 9.49m NOK

+48.7%

Total assets

8.03m NOK 11.61m NOK

+44.6%

↑
Revenue rose

Operating income / revenue moved from 1.15m NOK to 4.95m NOK (+332.2% YoY). Calculated
↑
Equity strengthened

Book equity 108.6k NOK → 9.23m NOK (equity ratio 1.4% → 79.5%). Calculated
↑
Cash rose

Bank deposits 6.38m NOK → 9.49m NOK (+48.7% YoY). Calculated
↑
Owners injected capital

Paid-in equity rose 17.73m NOK → 23.19m NOK (+5.47m NOK). Reported fact

↓
Operating result weakened

Operating result -2.68m NOK → -3.47m NOK (op. margin -233.6% → -70.1%). Calculated

·
Payroll increased

Salary cost 2.07m NOK → 2.30m NOK (181% → 47% of revenue). Calculated